Iris Dorbian

ElevateBio racks up $150 mln Series A

Cambridge, Massachusetts-based ElevateBio, a biotech holding company, has secured $150 million in Series A financing. The investors included UBS Oncology Impact Fund, EcoR1 Capital, Redmile Group and Samsara BioCapital.

Phyn grabs $12 mln

Torrance, California-based Phyn, a provider of intelligent water solutions, has raised $12 million in funding. The investors were Uponor and Belkin.

Rocean pulls in over $6 mln

New York City-based Rocean, a connected water countertop device, has secured over $6 million in funding. Blue was the lead investor.

USVP racks up over $292 mln for twelfth fund

U.S. Venture Partners has raised over $292 million for its twelfth fund, according to an SEC filing. The target is $350 million. Based in Menlo Park, California, the venture firm invests in technology and healthcare.

Insurance tech startup OneDegree rakes in over $30 mln

Hong Kong-based OneDegree, an insurance tech startup, has raised over $30 million in funding. BitRock Capital led the round with participation from other investors that included Cyberport Macro Fund and Cathay Venture.

Grain snags $10 mln Series B

Grain, an online food company, has raised $10 million Series B funding. Singha Ventures led the round with participation from other investors that included Genesis Alternative Ventures, Sass Corp, K2 Global, FoodXervices, Majuven, Openspace Ventures, Raging Bull and Cento Ventures.

Kairos Ventures leads $6 mln round for Integra Devices

California-based Integra Devices, a next-generation micro-device company, has secured $6 million in funding. Kairos Ventures led the round.

Understory procures $5.25 mln Series B

Understory, a weather network and analytics company, has secured $5.25 million in Series B funding. True Ventures led the round with participation from 4490 Ventures and Revolution’s Rise of the Rest Seed Fund.

Overhaul Group pulls in $7 mln

Overhaul Group Inc, a supply chain integrity solutions provider, has secured $7 million in funding. The investors included Abbey International Finance.

Twentyeight-Seven Therapeutics nabs $15 mln

Sofinnova Partners has led a $15 million round for Twentyeight-Seven Therapeutics Inc. Also, Osage University Partner participated in the financing. Based in Watertown, Massachusetts, Twentyeight-Seven Therapeutics is a biotech company focused on the modulation of RNA to treat cancer and other human diseases.